Form 4: Moderna CFO Reports Stock Transaction
Insider Transaction (Form 4)
James M Mock, Chief Financial Officer of Moderna, Inc., reported multiple transactions in common stock on August 27, 2026.
Summary
- Option exercise/conversion: acquired 774 Common Stock on August 27, 2026; holds 67,210 after (Direct).
- Tax/exercise-price withholding: disposed of 375 Common Stock at $149.66 ($56,122) on August 27, 2026; holds 66,835 after (Direct).
- Option exercise/conversion: acquired 329 Common Stock on August 28, 2026; holds 67,164 after (Direct).
- Tax/exercise-price withholding: disposed of 160 Common Stock at $142.77 ($22,843) on August 28, 2026; holds 67,004 after (Direct).
- Option exercise/conversion: disposed of 774 Restricted Stock Units on August 27, 2026; holds 4,642 after (Direct).
- Option exercise/conversion: disposed of 329 Restricted Stock Units on August 28, 2026; holds 658 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James M Mock — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Option exercise/conversion | Common Stock | 774 | — | — | 67,210 |
| 2026-08-27 | Tax/exercise-price withholding | Common Stock | 375 | $150 | $56.1K | 66,835 |
| 2026-08-28 | Option exercise/conversion | Common Stock | 329 | — | — | 67,164 |
| 2026-08-28 | Tax/exercise-price withholding | Common Stock | 160 | $143 | $22.8K | 67,004 |
| 2026-08-27 | Option exercise/conversion | Restricted Stock Units | 774 | — | — | 4,642 |
| 2026-08-28 | Option exercise/conversion | Restricted Stock Units | 329 | — | — | 658 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Option exercise/conversion (774 shares) |
| 2026-08-27 | Tax/exercise-price withholding (375 shares) |
| 2026-08-28 | Option exercise/conversion (329 shares) |
| 2026-08-28 | Tax/exercise-price withholding (160 shares) |
| 2026-08-27 | Option exercise/conversion (774 shares) |
| 2026-08-28 | Option exercise/conversion (329 shares) |
Keywords
insider transaction, Form 4, MRNA, Moderna, Inc., neutral, James M Mock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.